Development and Manufacture of Hi6 Powder for Solution

Development and manufacture of HI-6 DMS powder for solution product. The Authority requires a supplier to provide services for the development, scale-up, clinical and potential future commercial supply. The supplier will be providing product into UK, Canadian and European Union regulatory areas as a minimum. The supplier will provide all supporting manufacturing studies necessary for all stages of product development. The product should be considered light sensitive for the purposes of long-term storage, but specific measures should not be necessary for production processes. The Authority will provide the Active Pharmaceutical to the supplier for all activities.